BMJ UK BMJ Americas BMJ Brazil BMJ China BMJ India

Through scenario planning, we have developed a deep understanding of the critical factors that are driving transformative change in global research.

Scenario planning leadership

Our scenario planning is a collaborative tool, which has raised important questions about the future of global research.

We combine our industry knowledge and specialist expertise to reflect on uncertainties, anticipate possible industry shifts, and envision ways to act appropriately.

Explore our four plausible but challenging future scenarios that help us view the future of scientific research here.

  • Anca Babor

    Director of Strategy

  • Claire Rawlinson

    Publisher, BMJ Journals

  • Dr Luisa Dillner

    Head of Research and Development

  • Dr Ashley McKimm

    Director of Partnership Development

  • Prashant Mishra

    Managing Director - India & South Asia

  • Glen Campbell

    Managing Director - BMJ The Americas

  • Dr Fiona Godlee

    Editor-in-Chief, The BMJ & Editorial Director, BMJ

Anca Babor

Director of Strategy

Anca is an executive member, responsible for the development of the company's strategic priorities as well as its partnerships and acquisitions.

She joined BMJ in 2013, having previously held various roles in sales and strategy with Thomson Reuters, Shell and GlaxoSmithKline. Anca holds an MBA degree from INSEAD and is on the Board of Trustees of the Strategic Planning Society.

Claire Rawlinson

Publisher, BMJ Journals

Claire has 14 years' STM publishing experience. Prior to joining BMJ in 2016, Claire provided editorial strategic direction within senior roles for The Royal Society, The British Institute of Radiology, and Oxford University Press.

With an undergraduate degree in biological sciences, she is an advocate of open science and the application of those principles to scholarly communication. Claire recently launched BMJ Open Science, BMJ’s first pre-clinical journal.

Dr Luisa Dillner

Head of Research and Development

Luisa works closely with BMJ’s customers to develop our clinical decision support tools, journals and patient information. She is responsible for the quantitative and qualitative research, usability testing and information architecture research that takes place at the company’s innovative CoLab.

Luisa’s evidence-based findings and insights with third-party medical professionals stimulate product propositions and improve user experiences for the full BMJ product portfolio.

Luisa is a doctor who trained for six years in general surgery. She is also a journalist and author - spending two years as the health editor for the Guardian, and authoring three books.

Dr Ashley McKimm

Director of Partnership Development

Ashley oversees the partnerships BMJ has with over 110 global funders, associations, governments, and commercial organisations. Building these collaborations and joint ventures around the globe aligns with our vision of helping to create a healthier world.

Previously, Ashley practised as a doctor in the UK before being seconded as a clinical advisor to NHS England’s National Medical Director, Professor Sir Bruce Keogh. He is also past director of the International Forum on Quality and Safety in Healthcare (Europe and Asia Pacific) and past chairman of the UK Medical Journalists' Association.

Prashant Mishra

Managing Director - India & South Asia

Prashant conceived and developed BMJ’s base in India and South Asian region. He leads a team of 30, all of whom are passionate about and works relentlessly towards improving healthcare outcomes in India.

Prashant was employed by Elsevier and Wolters Kluwer Health before joining BMJ in 2008 as country manager. He has an MA in microbiology and management, and is currently completing an executive fellowship programme in management: business communication, at the Indian Institute of Management Lucknow.

Glen Campbell

Managing Director - BMJ The Americas

Glen joined BMJ in 2013 and enjoys building on BMJ’s current success in this market to realise its full potential. He brings more than 34 years of Science, Technology & Medicine publishing to this role. Glen was previously responsible for the worldwide journals programme of Elsevier Health Sciences, overseeing more than 400 journals in the health sciences.

He serves on the American Medical Publishers Committee and is Chair of Board of Directors of the National Library of Medicine, and past Chair of the Professional and Scholarly Publishing Division of the Association of American Publishers.

Dr Fiona Godlee

Editor-in-Chief, The BMJ & Editorial Director, BMJ

Fi is The BMJ journal’s 16th editor in chief and the first woman in the role. She is also editorial director of BMJ the company, responsible for ensuring the editorial integrity of all or our products and services.

She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. Fi has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence-based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment.